Cannabinoid Encyclopedia

Focused research review

What do we know about CBC safety?

What evidence connects CBC with safety, tolerability, adverse-event, impairment, or formulation-specific outcomes?

Updated July 2026 21 research sources Human and early research

The short answer

What is the bottom line?

Research has examined CBC safety. This page brings together 6 human-study sources, 6 research reviews, and 7 lab, animal, or mechanism sources. The source set includes human research as well as earlier-stage studies. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CBC safety.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CBC safety covers Safety, tolerability, adverse-event, impairment, toxicity, or formulation-spe...; those areas should not be combined into one claim. 1

  2. 2

    The source set includes human research as well as earlier-stage studies. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CBC safety

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

Safety, tolerability, adverse-event, impairment, toxicity, or formulation-spe...

This part of the literature focuses on Safety, tolerability, adverse-event, impairment, toxicity, or formulation-spe.... Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

6 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

6 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

7 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 2 of 21 research sources could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on CBC safety is not one kind of study. This source set includes 5 narrative or expert reviews, 4 animal studies, 4 cell or laboratory studies, and 2 clinical studies in people. 3

The recorded populations or models include people or patients (6 sources), animal models (4 sources), and cells or tissue models (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns (21 sources). Closely related outcome names can still describe different measurements. 5

The CBC safety source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

A systematic review of analytical methodologies capable of analysing phytocannabinoids in cosmetics.

On this page, this source examines CBC and safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns. 1

Study type
systematic review or meta-analysis
Outcome focus
safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns
Evidence stage
evidence still limited

narrative or expert review

The Potential of Cannabichromene (CBC) as a Therapeutic Agent.

On this page, this source examines CBC and safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns. 2

Study type
narrative or expert review
Outcome focus
safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns
Evidence stage
evidence still limited

cell or laboratory study

Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine.

On this page, this source examines CBC and safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns. 3

Study type
cell or laboratory study
Population or model
people or patients
Outcome focus
safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns
Evidence stage
mechanism-focused research

animal study

Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents.

On this page, this source examines CBC and safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns. 4

Study type
animal study
Population or model
animal models
Outcome focus
safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns
Evidence stage
preclinical research

human research

Transcriptomic comparison on the mechanism of action of four major constituent cannabinoids in hemp extract.

On this page, this source examines CBC and safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns. 5

Population or model
people or patients
Outcome focus
safety, tolerability, adverse-event, impairment, toxicity, or formulation-specific concerns
Evidence stage
human research

Safety and limits

What should readers keep in mind?

Research on CBC safety should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects CBC with safety, tolerability, adverse-event, impairment, or formulation-specific outcomes?

Relevant research is collected here. The source set includes human research as well as earlier-stage studies. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    A systematic review of analytical methodologies capable of analysing phytocannabinoids in cosmetics. systematic review or meta-analysis; evidence still limited PubMed 38229238 DOI 10.1002/dta.3628
  2. 2
    The Potential of Cannabichromene (CBC) as a Therapeutic Agent. narrative or expert review; evidence still limited PubMed 38777605 DOI 10.1124/jpet.124.002166
  3. 3
    Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine. cell or laboratory study; mechanism-focused research PubMed 42163693 DOI 10.2174/0109298673390667251201115054
  4. 4
    Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents. animal study; preclinical research PubMed 40580638 DOI 10.1016/j.ejmech.2025.117888
  5. 5
    Transcriptomic comparison on the mechanism of action of four major constituent cannabinoids in hemp extract. human research PubMed 42057192 DOI 10.1186/s42238-026-00432-w
  6. 6
    Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs. clinical study in people; mechanism-focused research PubMed 33134364 DOI 10.3389/fvets.2020.583404
  7. 7
    The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial. clinical study in people; human research PubMed 37162192 DOI 10.1080/27697061.2023.2203221
  8. 8
    Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era. narrative or expert review; evidence still limited PubMed 32628766 DOI 10.1093/clinchem/hvaa113
  9. 9
    Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. narrative or expert review; evidence still limited PubMed 40872492 DOI 10.3390/ph18081101
  10. 10
    Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review. narrative or expert review; evidence still limited PubMed 37630401 DOI 10.3390/molecules28166149
  11. 11
    Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy? narrative or expert review; evidence still limited PubMed 37414155 DOI 10.1016/j.arr.2023.101998
  12. 12
    Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites. animal study; evidence still limited PubMed 37396845 DOI 10.1016/j.toxrep.2023.06.001
See all 21 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinoids: Therapeutic Applications, Mechanisms, and Challenges in Modern Medicine. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 42163693
  2. Transcriptomic comparison on the mechanism of action of four major constituent cannabinoids in hemp extract. human research / 1 linked research note PubMed 42057192
  3. The Potential of Cannabichromene (CBC) as a Therapeutic Agent. narrative or expert review; evidence still limited / 1 linked research note PubMed 38777605
  4. Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. narrative or expert review; evidence still limited / 1 linked research note PubMed 40872492
  5. Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 37630401
  6. The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial. clinical study in people; human research / 1 linked research note PubMed 37162192
  7. A systematic review of analytical methodologies capable of analysing phytocannabinoids in cosmetics. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 38229238
  8. Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents. animal study; preclinical research / 1 linked research note PubMed 40580638
  9. Toxicological Evaluation and Pain Assessment of Four Minor Cannabinoids Following 14-Day Oral Administration in Rats. animal study; preclinical research / 1 linked research note PubMed 37721989
  10. CBD, a precursor of THC in e-cigarettes. evidence still limited / 1 linked research note PubMed 33903673
  11. The antinociceptive activity and mechanism of action of cannabigerol. animal study; preclinical research / 1 linked research note PubMed 36916438
  12. Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy? narrative or expert review; evidence still limited / 1 linked research note PubMed 37414155
  13. Cannabigerol and Cannabichromene Induce Lung Cancer Cell Death and Apoptosis-Contribution of PPARα to Cannabigerol Effects. cell or laboratory study; evidence still limited / 1 linked research note PubMed 42352060
  14. Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era. narrative or expert review; evidence still limited / 1 linked research note PubMed 32628766
  15. Cannabis Vaping: Existing and Emerging Modalities, Chemistry, and Pulmonary Toxicology. evidence still limited / 1 linked research note PubMed 34622654
  16. Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs. clinical study in people; mechanism-focused research / 1 linked research note PubMed 33134364
  17. Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites. animal study; evidence still limited / 1 linked research note PubMed 37396845
  18. Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells. cell or laboratory study; evidence still limited / 1 linked research note PubMed 39172143
  19. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. mechanism-focused research / 1 linked research note PubMed 20619971
  20. Mapping the research landscape of minor cannabinoids: a bibliometric analysis of research trends and hotspots. mechanism-focused research / 1 linked research note PubMed 41668212
  21. Development and validation of a fit-for-purpose UHPLC-ESI-MS/MS method for the quantitation of cannabinoids in different matrices. cell or laboratory study; evidence still limited / 1 linked research note PubMed 36854205